Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis — Daniel De Backer (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis
Article
2006
en
Authors
+3 more
DB
Daniel De Backer
CV
Colin Verdant
MC
Marialuisa Chierego
Abstract
1 min read
DAA administration rapidly improves sepsis-induced microvascular alterations, whereas its cessation is associated with a transient deterioration.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2006
Drotrecogin alfa (activated) in the treatment of severe sepsis
Jean Louis Vincent
Article
2003
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
E. Wesley Ely
,
Pierre‐François Laterre
,
Derek C. Angus
,
Jeffrey D. Helterbrand
,
Howard Levy
,
Jean-François Dhainaut
,
Jean Louis Vincent
,
William L. Macias
,
Gordon R. Bernard
Article
2007
Drotrecogin alfa (activated): the treatment for severe sepsis?
Jean Louis Vincent
Article
2007
Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
Jean Louis Vincent
Article
2002
Drotrecogin alfa: a new approach in the treatment of severe sepsis
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.